Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-325343
Filing Date
2013-08-08
Accepted
2013-08-08 06:08:09
Documents
14
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d578413d10q.htm 10-Q 207215
2 EX-10.AL d578413dex10al.htm EX-10.AL 13950
3 EX-10.AM d578413dex10am.htm EX-10.AM 10694
4 EX-31.1 d578413dex311.htm EX-31.1 9038
5 EX-31.2 d578413dex312.htm EX-31.2 9030
6 EX-32.1 d578413dex321.htm EX-32.1 3177
7 EX-32.2 d578413dex322.htm EX-32.2 3167
14 GRAPHIC g578413g82k37.jpg GRAPHIC 16622
  Complete submission text file 0001193125-13-325343.txt   3609549

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT appa-20130630.xml EX-101.INS 325770
9 XBRL TAXONOMY EXTENSION SCHEMA appa-20130630.xsd EX-101.SCH 26373
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appa-20130630_cal.xml EX-101.CAL 18342
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appa-20130630_def.xml EX-101.DEF 118680
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE appa-20130630_lab.xml EX-101.LAB 203027
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appa-20130630_pre.xml EX-101.PRE 120094
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 131019819
SIC: 2834 Pharmaceutical Preparations